Burkina Faso vs Niger: Cause of death, by non-communicable diseases, ages 60+, female
Burkina Faso
64.4%
in 2021
Niger
63.9%
in 2021
Burkina Faso rank
150th
Niger rank
153rd
Cause of death, by non-communicable diseases, ages 60+, female over time
- Burkina Faso
- Niger
How they compare
Burkina Faso currently reports 64.4% against 63.9% in Niger, a difference of 0.5%.
Across all 6 years both countries report, Burkina Faso has been ahead every year.
Burkina Faso ranks 150th and Niger ranks 153rd of 185 countries.
Burkina Faso has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.9% | 55.4% | 4.5% | Burkina Faso |
| 2010s | 70.5% | 66.2% | 4.2% | Burkina Faso |
| 2020s | 67.6% | 65.3% | 2.4% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Burkina Faso or Niger?
- Burkina Faso, at 64.4% against 63.9% in Niger as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Burkina Faso and Niger?
- 0.5%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Niger?
- 6 years are reported by both, from 2000 to 2021.
- How do Burkina Faso and Niger rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Burkina Faso ranks 150th and Niger ranks 153rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.